Vaccines against Covid-19 were developed on the basis of protein S, before it had the mutations identified in these variants. Although research conducted so far is less effective against variants and continues to offer protection against severe forms of Covid-19, further research is ongoing.
WHO is working with every country in the world to help coordinate the key stages of this vaccine manufacturing and development process. In particular, to facilitate equitable access for all countries to vaccines against Covid-19 and that they are safe and effective for the billions of people who need them.
%0 Journal Article
%1 julia_san_miguel_rodriguez_2021_5195600
%A Rodríguez, Julia San Miguel
%A Barbero, Julita Rodríguez
%A Hernández, Angel San Miguel
%A Rodríguez, Angel San Miguel
%A Rodríguez, María San Miguel
%D 2021
%J GSC Advanced Research and Reviews
%K Coronavirus
%N 2
%P 045-057
%R 10.30574/gscarr.2021.8.2.0143
%T Vaccines against SARS-COV-2
%U https://gsconlinepress.com/journals/gscarr/content/vaccines-against-sars-cov-2
%V 8
%X Vaccines against Covid-19 were developed on the basis of protein S, before it had the mutations identified in these variants. Although research conducted so far is less effective against variants and continues to offer protection against severe forms of Covid-19, further research is ongoing.
WHO is working with every country in the world to help coordinate the key stages of this vaccine manufacturing and development process. In particular, to facilitate equitable access for all countries to vaccines against Covid-19 and that they are safe and effective for the billions of people who need them.
@article{julia_san_miguel_rodriguez_2021_5195600,
abstract = {Vaccines against Covid-19 were developed on the basis of protein S, before it had the mutations identified in these variants. Although research conducted so far is less effective against variants and continues to offer protection against severe forms of Covid-19, further research is ongoing.
WHO is working with every country in the world to help coordinate the key stages of this vaccine manufacturing and development process. In particular, to facilitate equitable access for all countries to vaccines against Covid-19 and that they are safe and effective for the billions of people who need them.},
added-at = {2021-08-13T11:22:18.000+0200},
author = {Rodríguez, Julia San Miguel and Barbero, Julita Rodríguez and Hernández, Angel San Miguel and Rodríguez, Angel San Miguel and Rodríguez, María San Miguel},
biburl = {https://www.bibsonomy.org/bibtex/2ead04638d7c9cc42e391fc4bf492cc48/gscarrjournal},
doi = {10.30574/gscarr.2021.8.2.0143},
interhash = {090170e0d9b88ff7d3c350a45d7b5837},
intrahash = {ead04638d7c9cc42e391fc4bf492cc48},
journal = {GSC Advanced Research and Reviews},
keywords = {Coronavirus},
month = aug,
number = 2,
pages = {045-057},
timestamp = {2021-08-13T11:22:18.000+0200},
title = {Vaccines against SARS-COV-2},
url = {https://gsconlinepress.com/journals/gscarr/content/vaccines-against-sars-cov-2},
volume = 8,
year = 2021
}